Integra LifeSciences
(Nasdaq:IART)
this week announced it appointed Lea Daniels Knight as executive Vice President and chief financial officer, effective June 28.
Knight has more than 30 years of experience in global companies with significant operating scale and complexity. She most recently was executive VP of business finance for Booz Allen Hamilton, where she was responsible for providing strategic and financial leadership to all of the company’s business sectors to support above-market growth.
“I deeply admire the company’s purpose of restoring patients’ lives and its mission of driving innovation and setting new treatment standards of care as it aligns with my own values,” Knight said in a news release. “I look forward to leveraging my experience in finance, healthcare, global business services and operational organizations, and build on Integra’s leadership position in surgical, neurologic and regenerative care to create long-term value for our customers, patients and shareholders.”
She has also worked at Johnson & Johnson in finance roles with increasing responsibility, including as CFO of J&J’s North American pharmaceuticals business. Throughout her tenure at J&J, she helped drive cost optimization initiatives, manage risk and create innovative solutions across six of the organization’s operating companies within their consumer, pharmaceutical and corporate sectors.
“Lea brings a wealth of finance, accounting, and extensive healthcare industry experience, and has the necessary capabilities to successfully partner with me and our executive leadership to lead change and drive growth and financial outcomes,” CEO and President Jan De Witte said. “She is passionate about leadership and talent development with broad experience leading geographically dispersed teams that have outperformed and created shareholder value.”
